However, in the present study, we found that targeted reduction of SIRT3 led to downregulation of ATF4 expression at the mRNA level, whereas rescued expression of ATF4 in SIRT3-deficient GBM cells restored SLC7A11 expression significantly (Fig. 9). The gene discussed is ATF4; the disease is glioblastoma.